Concepedia

Author

Anja Lorch

Heinrich Heine University DüsseldorfORCID

Also Known As

A. Lorch, A.C. Lorch, ALICE LORCH, Alice C Lorch, Alice C. Lorch, Alice Lorch, Anja Lorch, Anna Lorch, Carrión, Albert, El Saadany, Tämer

300

Publications

5.5K

Citations

34

H-Index

27

Concepts

All Affiliations

Heinrich Heine University DüsseldorfUniversität HamburgVivantes KlinikumUniversity Medical Center Hamburg-EppendorfDüsseldorf University Hospital
AL

About

Anja Lorch is an author at Heinrich Heine University Düsseldorf specializing in medicine, urology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

16

1.2K

2

Pathology

8

8

365

3

Obstetrics

3

3

56

4

Health Sciences

1

1

12

5

Neurology

1

1

14

Anja Lorch

×

30

Publications

2.9K

Citations

21

H-Index

YearCitations

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu,

The Lancet Oncology

2021

627

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

Klaus‐Peter Dieckmann, Arlo Radtke, Lajos Géczi,

Journal of Clinical Oncology

2019

330

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

J. Beyer, Peter Albers, Renske Altena,

Annals of Oncology

2012

320

ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

Friedemann Honecker, Jorge Aparicio, Daniel M. Berney,

Annals of Oncology

2018

319

Conventional-Dose Versus High-Dose Chemotherapy As First Salvage Treatment in Male Patients With Metastatic Germ Cell Tumors: Evidence From a Large International Database

Anja Lorch, Caroline Mollévi, Andrew Kramar,

Journal of Clinical Oncology

2011

263

Single Versus Sequential High-Dose Chemotherapy in Patients With Relapsed or Refractory Germ Cell Tumors: A Prospective Randomized Multicenter Trial of the German Testicular Cancer Study Group

Anja Lorch, Christian Kollmannsberger, J. T. Hartmann,

Journal of Clinical Oncology

2007

144

Sequential Versus Single High-Dose Chemotherapy in Patients With Relapsed or Refractory Germ Cell Tumors: Long-Term Results of a Prospective Randomized Trial

Anja Lorch, Antje Kleinhans, Andrew Kramar,

Journal of Clinical Oncology

2012

111

A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).

Thomas Powles, Alejo Rodríguez‐Vida, Ignacio Durán,

Journal of Clinical Oncology

2018

90

Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options—An Analysis From the Global Germ Cell Cancer Group

Darren R. Feldman, Anja Lorch, Andrew Kramar,

Journal of Clinical Oncology

2015

88

Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST)

Andreas Hiester, Yue Che, Achim Lusch,

European Urology

2022

86

Page 1